home All News open_in_new Full Article

Former Silicon Valley DNA Darling 23andMe Acquired by Regeneron Pharmaceuticals

Regeneron Pharmaceuticals has announced a plan to acquire the bankrupt genetic testing company 23andMe for $256 million, raising privacy concerns as the pharmaceutical giant will gain access to the genetic data of over 15 million customers. The post Former Silicon Valley DNA Darling 23andMe Acquired by Regeneron Pharmaceuticals appeared first on Breitbart.


today 3 d. ago attach_file Politics

attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Economics
attach_file Events
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Politics
attach_file Sport
attach_file Politics
attach_file Politics
attach_file Technology
attach_file Events
attach_file Politics
attach_file Politics
attach_file Economics
attach_file Technology


ID: 1757831013
Add Watch Country

arrow_drop_down